Giuseppe Antoniazzi - FibroTech Solutions
Pioneering chemical probe for the early diagnosis and monitoring of fibrosis
Fibrotic diseases pose a significant health challenge. Current diagnostic methods often fail in early detection and effective monitoring, leading to delayed intervention and dramatically shortened life expectancy for patients. Our chemical probe – FibroDetect Probe – addresses this unmet need for innovative diagnostic tools and interventions by targeting the hallmark of fibrotic ECM pathophysiology: excessive collagen deposition and overexpression of lysyl oxidase (LOX). Our technology will enable clinicians to make more informed and timely diagnoses and provide essential readouts to assess the efficacy of anti-fibrotic drugs.
Giuseppe Antoninazzi